TE_119
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2b_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | DHRS3 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 1.31 |
| Counts of samples | TCGA_tumor:28; TCGA_normal:4; GTEx:20 |
| TSS | chr1(-):12573508 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_119.1 | DHRS3 | Chimeric | Non-coding | Non-coding | chr1(-):12568404,12568424,12572728,12572853,12573398,12573509 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
